2024-11-20 01:36:19
Innoforce Pharmaceuticals to Participate in BIO International Digital Convention
Health/ 2023-07-22
Innoforce Pharmaceuticals to Participate...

HANGZHOU,Chinaand ROCKVILLE,Md.,June 8,2021-- Innoforce Pharmaceuticals ("Innoforce"),an innovation and partnership-focused biopha...

Antengene's Partner Karyopharm Therapeutics Announces Updated Data of Eltanexor in Patients with Hypomethylating Agent Refractory MDS
Corporate/ 2023-07-23
Antengene's Partner Karyopharm Ther...

--Of the 15 patients evaluable for efficacy,7 (47%) had mCR and 5 (33%) had SD for a total disease control rate of 80%--

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release